MAPK3 and asthma: In this work we confirmed that LPS phosphorylates JAK2/STAT3, ERK1/2 and P38 in neutrophils from severe asthma and COPD patients which were attenuated by LAS194046, showing synergic inhibitory effects when combined with fluticasone propionate.